Because of their extraordinary ability to disrupt the natural structure of nucleic acids, metal
complexes could be used in cancer therapy. In this study, cyclohexylglycine (HL) as a ligand …

Small molecules have potential usage in cancer therapy due to their remarkable potency of
disarranging the natural structure of nucleic acids. In this study, two complexes [Pt (NH3) 2 …

For investigating reduction of side effects of commercial anticancer drugs, such as cisplatin,
three new platinum complexes with glycine derivatives and the formula of [Pt (R-amine) 2 (R …

cis-[Pt (ambim) Cl2] 1 (where, ambim= 2-aminomethylbenzimidazole) has been synthesized
and characterized by spectroscopic methods. Reaction kinetics between the hydrolyzed …

A consistent series of Pt (II) polypyridyl complexes (ie, LDP‐10–25), previously obtained and
characterized by our research group, underwent extensive biological investigations to verify …

In this study, two new anticancer platinum complexes formulated as [Pt (bpy)(L)] NO 3 were
synthesized using the iso and tert-pentylglycine ligands, two structural isomer ligands, to …

Nine tridentate Schiff base ligands of the type (N^ N^ O) were synthesized from reactions of
primary amines {2-picolylamine (Py), N-phenyl-1, 2-diaminobenzene (PhN), and N-phenyl …

A dichloro Pt (II) complex with N-heterocyclic amine cis-Pt (PIEAM) Cl2, C-1 (where PIEAM=
1-(2-aminoethyl) piperidine) was synthesized and hydrolyzed to the corresponding [Pt …

The reaction between [PtCl2 (LL)](LL= dppe, dppp, dppb, dppf, Phen and Bipy) or [PtCl2
(PPh3) 2] with 1-benzyl-3-phenylthiourea (H2BPT) in a basic medium (CHCl3/EtOH) created …

The bioactivity and cytotoxic property of cis‐[Pt (AEP) Cl2](C‐1);[Pt (AEP)(OH2) 2](NO3) 2 (C‐
2);[Pt (AEP)(GSH)(C‐3)]; and [Pt (AEP)(DL‐meth)] 2+(C‐4)(where AEP= 1‐[2‐Aminoethyl] …